SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-004412
Filing Date
2023-02-13
Accepted
2023-02-13 11:29:52
Documents
13
Period of Report
2023-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64724
  Complete submission text file 0001493152-23-004412.txt   299819

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aeha-20230210.xsd EX-101.SCH 4404
3 XBRL DEFINITION FILE aeha-20230210_def.xml EX-101.DEF 27307
4 XBRL LABEL FILE aeha-20230210_lab.xml EX-101.LAB 37849
5 XBRL PRESENTATION FILE aeha-20230210_pre.xml EX-101.PRE 25927
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7169
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Aesther Healthcare Acquisition Corp. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 23615833
SIC: 2834 Pharmaceutical Preparations